This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by She, R. C.
Right arrow Articles by Petti, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by She, R. C.
Right arrow Articles by Petti, C. A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, July 2007, p. 2212-2214, Vol. 45, No. 7
0095-1137/07/$08.00+0     doi:10.1128/JCM.00548-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Limited Applicability of Direct Fluorescent-Antibody Testing for Bordetella sp. and Legionella sp. Specimens for the Clinical Microbiology Laboratory{triangledown}

Rosemary C. She,1* Erick Billetdeaux,2 Amit R. Phansalkar,2 and Cathy A. Petti1,2,3

Department of Pathology, University of Utah, 30 North 1900 East, Salt Lake City, Utah 84132,1 Associated Regional University Pathologists Institute for Research and Development, 500 Chipeta Way, Salt Lake City, Utah 84108,2 Department of Medicine, University of Utah, Salt Lake City, Utah3

Received 12 March 2007/ Accepted 11 May 2007

The rapid diagnosis of infections with Bordetella and Legionella species is important for patient management. With observed increases in direct fluorescent-antibody (DFA) testing volumes, we retrospectively compared the performance characteristics of DFA testing to those of culture and PCR. For Bordetella sp., samples were classified as positive by DFA testing (184 [3%] of 6,195 samples) and culture (150 [2%] of 6,251 samples) significantly less often than by PCR (2,557 [10%] of 26,929 samples). Of 360 samples tested by both DFA and PCR methods, 81 (16 by DFA testing and 79 by PCR) were determined to be positive for Bordetella, with a sensitivity and specificity of DFA testing of 18% and 99%, respectively. Of 1,426 samples tested by both DFA and culture methods, 48 (44 by DFA testing and 15 by culture) were determined to be positive for Bordetella, with a sensitivity and specificity of DFA testing of 73% and 98%, respectively. For Legionella sp., samples were identified as positive by DFA testing (31 [0.25%] of 12,597 samples) and culture (85 [0.6%] of 13,572 samples) significantly less often than by PCR (27 [4%] of 716 samples). Of 62 samples tested by both DFA and PCR methods, none were positive for Legionella sp. by DFA testing and 3 were positive by PCR. Of 3,923 samples tested by both DFA and culture methods, 22 (3 by DFA testing and 21 by culture) were positive for Legionella sp., with a sensitivity and specificity of DFA testing of 9.5% and 100%. Overall, DFA testing for Bordetella sp. and Legionella sp. is an insensitive method, and despite its continued popularity, clinical microbiology laboratories should not offer it when more sensitive tests like PCR are available.

* Corresponding author. Mailing address: Department of Pathology, University of Utah, 30 North 1900 East, Salt Lake City, UT 84132. Phone: (801) 581-2507. Fax: (801) 585-3831. E-mail: rosemary.she-bender{at}hsc.utah.edu

{triangledown} Published ahead of print on 23 May 2007.

Journal of Clinical Microbiology, July 2007, p. 2212-2214, Vol. 45, No. 7
0095-1137/07/$08.00+0     doi:10.1128/JCM.00548-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»